Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | MIF | P14174 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | EDNRB | P24530 | 1/20 | 0.35 |
| ▸ | EDNRA | P25101 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11637916 | 0.85 | KDM4E (0.36) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| Fluoride SCHEMBL11417624 | 0.82 | KDM4E (0.34) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL10381714 | 0.81 | MIF (0.34) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL5141716 | 0.81 | ALDH1A1 (0.40) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL11417625 | 0.80 | KDM4E (0.33) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL8112023 | 0.79 | KDM4E (0.34) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL10382671 | 0.77 | ALDH1A1 (0.50) | MAPTALDH1A1HPGDKDM4ERAB9A | |
| SCHEMBL68883 | 0.77 | HPGD (0.37) | MAPTALDH1A1HPGDNOTUMPOLB | |
| SCHEMBL9348168 | 0.76 | TP53 (0.40) | MAPTALDH1A1HPGDPLA2G1BATG4B | |
| SCHEMBL30460538 | 0.75 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11874601-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion-controlling agent | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-01-16 | — | — | US | disclosed |
| US-11874601-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion-controlling agent | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20220011665-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION-CONTROLLING AGENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-01-13 | — | — | US | disclosed |
| US-7291612-B2 | Immunomodulatory compounds | ACTIVE BIOTECH A.B. (SE) | 2007-11-06 | — | — | US | disclosed |
| EP-1813616-A2 | Pyrazoloquinolines with immunomodulating activity | Active Biotech AB (SE) | 2007-08-01 | — | — | EP | disclosed |
| EP-1562944-B1 | PYRAZOLOQUINOLINES WITH IMMUNOMODULATING ACTIVITY | ACTIVE BIOTECH AB (SE) | 2007-02-14 | — | — | EP | disclosed |
| US-20060217411-A1 | Immunomodulatory compounds | ACTIVE BIOTECH AB | 2006-09-28 | — | — | US | disclosed |
| US-7081456-B2 | Immunomodulatory compounds | ACTIVE BIOTECH AB (SE) | 2006-07-25 | — | — | US | disclosed |
| US-20050203118-A9 | Immunomodulatory compounds | ACTIVE BIOTECH AB (SE) | 2005-09-15 | — | — | US | disclosed |
| EP-1562944-A1 | PYRAZOLOQUINOLINES WITH IMMUNOMODULATING ACTIVITY | Active Biotech AB (SE) | 2005-08-17 | — | — | EP | disclosed |
| US-20040116461-A1 | Immunomodulatory compounds | ACTIVE BIOTECH AB (SE) | 2004-06-17 | — | — | US | disclosed |
| WO-2004048378-A1 | PYRAZOLOQUINOLINES WITH IMMUNOMODULATING ACTIVITY | ACTIVE BIOTECH AB (SE) | 2004-06-10 | — | — | WO | disclosed |
| CN-1053922-A | Therapeutical agent | BOOTS CO PLC (GB) | 1991-08-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203118-A9 | Immunomodulatory compounds | CD40, ICOS, CD40LG | MAPT 2428/4885ALDH1A1 3341/4885HPGD 2121/4885 |
| US-20220011665-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION-CONTROLLING AGENT | MRPS23, MRPS22, SLC11A2 | MAPT 4785/4885ALDH1A1 2227/4885HPGD 4266/4885 |
| US-11874601-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion-controlling agent | MRPS23, MRPS22, SLC11A2 | MAPT 4792/4885ALDH1A1 2173/4885HPGD 4260/4885 |
| US-20060217411-A1 | Immunomodulatory compounds | CD40, ICOS, CD40LG | MAPT 2428/4885ALDH1A1 3341/4885HPGD 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.